Olmesartan Inhibits Angiotensin II-Induced Migration of Vascular Smooth Muscle Cells Through Src and Mitogen-Activated Protein Kinase Pathways

• Egile Nagusiak: Yoji Kyotani (Egilea), Jing Zhao (Egilea), Sayuko Tomita (Egilea), Hitoshi Nakayama (Egilea), Minoru Isosaki (Egilea), Masayuki Uno (Egilea), Masanori Yoshizumi (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2010-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Clinical studies have shown that angiotensin-receptor blockers (ARBs) reduce the risk of cardiovascular diseases in hypertensive patients. It is assumed that the reduction of the risk by ARBs may be attributed in part to the inhibition of angiotensin II (AII)-induced vascular smooth muscle cell (VSM...